The Cigna Group has completed the sale of its Medicare businesses to Health Care Service. The transaction includes the divestment of Medicare Advantage, Cigna Supplemental Benefits, Medicare Part D, and CareAllies businesses. The majority of the proceeds will be allocated to share repurchases, aligning with Cigna's capital deployment priorities. Cigna will continue providing pharmacy benefit services and other solutions through Evernorth Health Services to the Medicare businesses as part of service agreements with HCSC for an agreed period.
Lawyers with the Pennsylvania Attorney General's Office signaled positive momentum for a long-term plan to save Delaware County's Crozer Health system on Wednesday during a bankruptcy hearing with Prospect Medical Holdings. At a lengthy hearing Wednesday, a deputy attorney general told the court: 'This is a very complex dance, and are cautiously optimistic we will have a long-term plan.' Attorneys said they are looking at Friday as a possible deadline to have a deal in the works.
The bill would allow the state's Health Care Authority to review all proposed mergers and acquisitions of hospitals and other health care facilities in New Mexico. The HCA would review the proposed transactions and approve or deny the deal. They would then outline specific conditions to preserve the quality, affordability and access to patient care. The bill now heads to the Senate.
Most previous CMS administrators have come to the job with experience working on health policy in state and federal government. But President Trump's pick is a relative newcomer. Oz worked as a heart surgeon at Columbia University and hosted a daytime talk show for 13 seasons before making an unsuccessful run for Senate in 2022.
An international team of scientists including those from Australia's Charles Darwin University (CDU) has developed a novel AI model known as ECgMPL, which can assess microscopic images of cells and tissue to identify endometrial cancer – one of the most common forms of reproductive tumors – with an impressive 99.26% accuracy. And the researchers say it can be adapted to identify a broad range of disease, including colorectal and oral cancer.